UNI 0.00% $1.06 unilife medical solutions limited

omi update

  1. 4,892 Posts.
    Unfortunately for our competitor OMI, they have failed in their attempt to successfully defend litigation brought by RTI for alleged patent infringements relating to the OMI safety syringe.

    Another competitor bites the dust.

    How reassuring to have the IP that UNI enjoys!

    Bring on 2010.

    dino
 
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.